In this study, we sought to more closely study the apoptotic pathway induced by a number of structurally distinct sigma-2 receptor ligands in pancreatic cancer, which have proven efficacious in preclincal models. The gene discussed is TMEM97; the disease is familial pancreatic carcinoma.